Postoperative single-dose interstitial high-dose-rate brachytherapy in therapy-resistant keloids

C. J.H. Hafkamp, O. Lapid, R. Dávila Fajardo, A. L. van de Kar, C. Koedooder, L. J. Stalpers, B. R. Pieters

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

15 Citaten (Scopus)

Samenvatting

Purpose Patients with keloids complain of the cosmetic aspect, pain, and pruritus. Many different therapies are being used for keloids. The aim of this study was to evaluate the recurrence rate and outcome after resection followed by a single-dose brachytherapy. Methods and materials Patients treated by resection of the keloid plus a single dose of 13 Gy high-dose-rate brachytherapy were evaluated at least 1 year after treatment. Clinical response and cosmesis were assessed by a plastic surgeon and by the patients using the Patient and Observer Scar Assessment Scale. Results Only 24 of the 61 invited patients responded to participate with the study; 29 keloids were evaluated. The recurrence rate was 24.1% after a median followup of 53 months (19–95 months). Patients scored on average 24.3 for their total Patient and Observer Scar Assessment Scale score (range 6–52), whereas the observer scored on average 14.6 (range 6–42). Conclusions This treatment has a higher recurrence rate than that reported in most other studies. This may be explained by differences in recurrence definition, differences in followup time among studies, and selection bias because of not contributing to the study. The cosmetic outcome for evaluated patients is relatively good. This treatment policy has the advantage that patients are treated in a single day.

Originele taal-2Engels
Pagina's (van-tot)415-420
Aantal pagina's6
TijdschriftBrachytherapy
Volume16
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - 1 mrt. 2017
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Postoperative single-dose interstitial high-dose-rate brachytherapy in therapy-resistant keloids'. Samen vormen ze een unieke vingerafdruk.

Citeer dit